Satoru Harada - Concepedia

Author

Satoru Harada

United States Military Academy ORCID

Also Known As

Harada S., S HARADA, S Harada, S. Harada, SHUN-ICHI HARADA, Satoru HARADA, Satoru Harada

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

United States Military Academy Hiroshima University Kyushu University The University of Osaka University of Tsukuba

About

Satoru Harada is an author at United States Military Academy specializing in medicine, cell biology, and health sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	17	962
2	Health Sciences	6	6	555
3	Public Health	3	3	49
4	Engineering	1	1	23
5	Biochemistry	1	1	52

Satoru Harada

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Induction of vascular endothelial growth factor expression by prostaglandin E2 and E1 in osteoblasts. Satoru Harada, Janice A. Nagy, Kathleen A. Sullivan, Journal of Clinical Investigation Prostaglandin E2AngiogenesisDevelopmental BiologyBone Morphogenic ProteinPhysiology	1994	398
Prostaglandin Receptor EP<sub>4</sub> Mediates the Bone Anabolic Effects of PGE<sub>2</sub> M. Machwate, Satoru Harada, Chih‐Tai Leu, Molecular Pharmacology	2001	167
A histologically distinctive interstitial pneumonia induced by overexpression of the interleukin 6, transforming growth factor beta 1, or platelet-derived growth factor B gene. Mitsuhiro Yoshida, Jun Sakuma, Seiji Hayashi, Proceedings of the National Academy of Sciences Collagen FibrilsInflammatory Lung DiseaseLung InflammationImmunologyPathology	1995	144
Association between Catechol-<i>O</i>-Methyltransferase Gene Polymorphisms and Wearing-Off and Dyskinesia in Parkinson’s Disease Miho Watanabe, Satoru Harada, Takashi Nakamura, Neuropsychobiology	2003	64
Prostaglandin F2 alpha stimulates proliferation of clonal osteoblastic MC3T3-E1 cells by up-regulation of insulin-like growth factor I receptors. Yoshiyuki Hakeda, Satoru Harada, Tomoko Matsumoto, Journal of Biological Chemistry Molecular PhysiologySignal TransductionInsulin-like Growth FactorBone Morphogenic ProteinGrowth Hormone	1991	57
Partial agonist/antagonist properties of androstenedione and 4-androsten-3β,17β-diol F. Chen, Kristin Knecht, Chih‐Tai Leu, The Journal of Steroid Biochemistry and Molecular Biology Molecular PharmacologyBiochemistryMedicineMechanism Of ActionPharmacological Agent	2004	52
Expression of the prostaglandin E2 (PGE2) receptor subtype EP4 and its regulation by PGE2 in osteoblastic cell lines and adult rat bone tissue11M.W. and M.M. contributed equally to this study. Miron Weinreb, M. Machwate, N. Shir, Bone Prostaglandin E2Molecular PhysiologyReceptor Subtype Ep4PhysiologyBone Tissue11m.w	2001	52
Prostaglandin E2 (PGE2) increases the number of rat bone marrow osteogenic stromal cells (BMSC) via binding the EP4 receptor, activating sphingosine kinase and inhibiting caspase activity Miron Weinreb, D. Shamir, M. Machwate, Prostaglandins Leukotrienes and Essential Fatty Acids InflammationProstaglandin E2Signal TransductionSclerostinBone Morphogenic Protein	2006	47
Expression and regulation of vascular endothelial growth factor in osteoblasts. Satoru Harada, Sevgi B. Rodan, Gideon A. Rodan PubMed InflammationProstaglandin E2AngiogenesisDevelopmental BiologyConditioned Media	1995	42
Regulation of transmembrane signal transduction of insulin-like growth factor II by competence type growth factors or viral ras p21. Toru Okamoto, Tomoichiro Asano, Satoru Harada, Journal of Biological Chemistry	1991	34

Page 1